000 01254 a2200325 4500
005 20250514184708.0
264 0 _c20050104
008 200501s 0 0 eng d
022 _a1040-8428
024 7 _a10.1016/S1040-8428(03)00172-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchagen, Frederik H E
245 0 0 _aImmune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
_h[electronic resource]
260 _bCritical reviews in oncology/hematology
_cApr 2004
300 _a51-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAntigen-Presenting Cells
_ximmunology
650 0 4 _aGenetic Therapy
_xadverse effects
650 0 4 _aGenetic Vectors
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
650 0 4 _aImmunity
650 0 4 _aImmunologic Factors
_xtherapeutic use
700 1 _aOssevoort, Martine
700 1 _aToes, Rene E M
700 1 _aHoeben, Rob C
773 0 _tCritical reviews in oncology/hematology
_gvol. 50
_gno. 1
_gp. 51-70
856 4 0 _uhttps://doi.org/10.1016/S1040-8428(03)00172-0
_zAvailable from publisher's website
999 _c14806941
_d14806941